Skip to content

Augmented visual feedback in upper limb stroke rehabilitation

The impact of augmented visual feedback in upper limb rehabilitation in sub-acute stroke: a pilot randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14268457
Enrollment
45
Registered
2011-09-21
Start date
2011-10-01
Completion date
Unknown
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Stroke, not specified as haemorrhage or infarction

Interventions

Stroke patients with upper limb impairments who meet inclusion criteria will be randomised into one of three groups: 1. Control group: This is standard care (SC) only and is usual therapy that would

Sponsors

University of Strathclyde (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged more than or equal to 18 years 2. Clinical diagnosis of stroke 3. Sub-acute stage of stroke (up to three months from time of onset of stroke) 4. Some movement in affected arm and/or hand - Action Research Arm Test (ARAT) score of 4-56 (57 max score) 5. Medically stable hence suitable for physical rehabilitation 6. Ability to understand and follow simple instructions 7. Able to give informed consent when assisted to do so with suitable communication aids

Exclusion criteria

Exclusion criteria: 1. Pre-existing upper limb deficits 2. Bilateral arm impairments 3. Severe visual or cognitive problems precluding participation in study protocol 4. Involved in any other intervention study

Design outcomes

Primary

MeasureTime frame
Arm function assessed by the Action Research Arm Test (ARAT) at baseline, six weeks and six months

Secondary

MeasureTime frame
1. Kinematic (temporal and spatial parameters) assessment measured using sensors worn during a section of the ARAT 2. Hand function measured by the 9 Hole Peg Test 3. Stroke Impact Scale - to evaluate quality of life and disability changes Measured at baseline, six weeks and six months Additional outcome measures: 1. A patient and therapist questionnaire at 6 weeks to assess the acceptance of the visualisation system from their perspective 2. The safety of intervention assessed by number and nature of adverse events at end of intervention period and at follow up 3. Acceptance of the visualisation system will be assessed by withdrawal or dropout rates from study

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026